PHARMACEUTICAL COMPOSITION OF BUFFERED INSULIN GLARGINE AND GLP-1 ANALOGUE

摘要

The invention relates to an aqueous pharmaceutical composition comprising: (a) from about 1 IU/ml to about 500 IU/ml of buffered insulin glargine, and (b) one or more pharmaceutically acceptable excipients, wherein the pharmaceutical composition has a pH between about 6 to about 9.